Tag Archives: Phase 3

Conference Recap – 2011 ACRP Global Conference and Exhibition

Posted on 26 May 2011 by Ask-Cato.com Contributor

The 2011 Association of Clinical Research Professionals (ACRP) Global Conference and Exhibition was held on 30 April – 03 May 2011 in Seattle, WA. The conference hosted 2,000 registrants including physicians, nurses, pharmacists, clinical research coordinators, clinical research associates, and other clinical research professionals. Continue reading →

Posted in Clinical Trials, Conferences and Meetings | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Recap of the 20th CED Biotech/Life Sciences Conference

Posted on 28 February 2011 by Ask-Cato.com Contributor

The 20th Annual Council for Entrepreneurial Development (CED) Biotech/Life Science Conference was held on 21-22 February 2011 in Raleigh, North Carolina. Continue reading →

Posted in Conferences and Meetings, Industry News, Venture Capital | Tagged , , , , , , , , , , , , | Comments Off

When Should You Write your Statistical Analysis Plans?

Posted on 24 May 2010 by Ask-Cato.com Contributor

Recently in the LinkedIn Biostatistics group, one user asked: A client wants me to prepare final SAP [statistical analysis plan] shortly after protocol and CRFs are finalized for a Phase 3 trial, to submit to FDA prior to start of … Continue reading →

Posted in Clinical Trials, Statistics | Tagged , , , , , , , , , , | 1 Comment

Tips for your Special Protocol Assessment

Posted on 7 April 2010 by Leo DiNapoli

A number of scientists with greatly different backgrounds can come up with completely different assessments. – Richard Leakey One question that we hear frequently is:  Can we apply for a Special Protocol Assessment (SPA) for our Phase 3 trial?  The … Continue reading →

Posted in FDA | Tagged , , , , , | Comments Off